Eli Lilly
3,667 hedge funds and large institutions have $687B invested in Eli Lilly in 2024 Q3 according to their latest regulatory filings, with 247 funds opening new positions, 1,567 increasing their positions, 1,393 reducing their positions, and 114 closing their positions.
117% more first-time investments, than exits
New positions opened: 247 | Existing positions closed: 114
12% more repeat investments, than reductions
Existing positions increased: 1,567 | Existing positions reduced: 1,393
3% more funds holding
Funds holding: 3,573 → 3,667 (+94)
0.57% less ownership
Funds ownership: 82.18% → 81.62% (-0.57%)
12% less call options, than puts
Call options by funds: $9.13B | Put options by funds: $10.4B
15% less funds holding in top 10
Funds holding in top 10: 556 → 474 (-82)
24% less capital inflows, than outflows
Capital inflows: $13.7B | Capital outflows: $18.1B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$750M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$722M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$569M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$526M |
| 5 |
Amundi
Paris,
France
|
+$492M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$1.73B |
| 2 |
BlackRock
New York
|
-$1.36B |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$1.31B |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$570M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$559M |
LLY Hedge Fund Activity: Q3 2024 in Review
3,667 of the 6,987 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2024, worth a combined $687B — down 2.8% from $707B a quarter earlier.
Buyers outnumbered sellers: 247 funds opened new LLY positions and 114 closed out — a net gain of 133 holders — while 1,567 added to existing stakes and 1,393 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $750M. The largest seller was Primecap Management, cutting an estimated $1.73B.
- 3,667 institutional investors held Eli Lilly (LLY) as of Q3 2024, up from 3,573 in Q2 2024.
- Funds reported $687B of Eli Lilly stock for Q3 2024, down 2.8% quarter-over-quarter.
- 247 funds opened new Eli Lilly positions in Q3 2024 and 114 closed out, a net change of +133 holders.
- The largest Eli Lilly buyer in Q3 2024 was Morgan Stanley, an estimated $750M added.
- The largest Eli Lilly seller in Q3 2024 was Primecap Management, an estimated $1.73B sold.
Based on aggregated 13F filings for Q3 2024.